Zimmer Biomet
Zimmer Biomet Holdings, Inc., commonly referred to as Zimmer Biomet, is a leading global medical device company headquartered in the United States. Founded in 1927, the company has established a strong presence in the orthopaedics and musculoskeletal sectors, focusing on innovative solutions for joint reconstruction, trauma, spine, and dental applications. With major operational regions across North America, Europe, and Asia-Pacific, Zimmer Biomet is renowned for its advanced products, including joint replacement implants and surgical instruments. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted partner in the healthcare industry. Notably, Zimmer Biomet's unique offerings, such as personalised surgical solutions and cutting-edge robotic technologies, enhance patient outcomes and streamline surgical procedures, solidifying its market leadership.
DitchCarbon Score
How does Zimmer Biomet's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zimmer Biomet's score of 51 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zimmer Biomet's reported carbon emissions
In 2023, Zimmer Biomet reported total greenhouse gas (GHG) emissions of approximately 83,000,000 kg CO2e, comprising 10,615,000 kg CO2e from Scope 1 and about 72,379,000 kg CO2e from Scope 2 (market-based). The company has set ambitious targets to reduce its absolute Scope 1 and 2 emissions by 55% by 2030, using 2017 as the base year. Additionally, Zimmer Biomet aims to decrease its Scope 3 emissions from purchased goods and services by 15% by 2030, relative to a 2019 baseline. In September 2023, Zimmer Biomet formalised its commitment to achieving net-zero GHG emissions by 2050, aligning with the Science Based Targets initiative (SBTi). This long-term goal underscores the company's dedication to sustainable practices within the healthcare equipment and supplies sector. The targets are designed to be consistent with the reductions necessary to limit global warming to 1.5°C, reflecting a proactive approach to climate change mitigation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | - | - | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zimmer Biomet is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
